The Effect of Celecoxib Administration on the Healing and Neovascularization of Colonic Anastomosis in Rats

REFERENCES

• Smith WL, Garavito RM, De Witt D. Prostaglandin endoperoxide H synthases (cycloxygenases)-1 and -2. J Biol Chem. 1996;271:33157–33160.
   PubMed Web of Science ®Google Scholar
• Gasparini G, Longo R, Sarmiento R, Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol. 2003;4:605–615.
   PubMed Web of Science ®Google Scholar
• Hinz B, Brune K. Cyclooxygenase-2–10 years later. J Pharmacol Exper Ther. 2002;300:367–375.
   PubMed Web of Science ®Google Scholar
• Nordentoft T, Romer J, Sorensen M. Sealing of gastrointestinal anastomoses with a fibrin glue-coated collagen patch: a safety study. J Invest Surg. 2007;20(6):363–369.
   PubMed Web of Science ®Google Scholar
• Chambers WM, Mortensen NJ. Postoperative leakage and abscess formation after colorectal surgery. Best Pract Res Clin Gastroenterol. 2004;18:865–880.
   PubMed Web of Science ®Google Scholar
• Halter F, Tarnawski AS, Schmassmann A, Cyclooxygenase 2 –implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives. Gut 2001;49:443–453.
   PubMed Web of Science ®Google Scholar
• Muller-Decker K, Hirschner W, Marks F, The effects of cyclooxygenase isozyme inhibition on incisional wound healing in mouse skin. J Invest Dermatol. 2002;119:1189–1195.
   PubMed Web of Science ®Google Scholar
• Thornton FJ, Barbul A. Healing in the gastrointestinal tract. Surg Clin North Am. 1997;77:549–573.
   PubMed Web of Science ®Google Scholar
• McMahon G. VEGF receptor signaling in tumour angiogenesis. Oncologist 2000;5:3–10.
   PubMedGoogle Scholar
• Fosslien E. Molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci. 2001; 31:325–348.
   PubMed Web of Science ®Google Scholar
• Wei D, Wang L, He Y, Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res. 2004;64:2030–2038.
   PubMed Web of Science ®Google Scholar
• Murphy G, Crabbe T. Gelatinases A and B. Methods Enzymol. 1995;248:470–484.
   PubMed Web of Science ®Google Scholar
• Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336–3340.
   PubMed Web of Science ®Google Scholar
• Tive L. Celecoxib clinical profile. Rheumatology 2000; 39:21–28.
   PubMedGoogle Scholar
• Bertagnolli MM, Eagle CJ, Zauber AG, Five year efficacy and safety analysis of the adenoma prevention with celecoxib (APC) trial. Cancer Prev Res (Phila). 2009;2:310–321.
   PubMed Web of Science ®Google Scholar
• Anderson WF, Umar A, Hawk ET. Cyclooxygenase inhibition in cancer prevention and treatment. Expert Opin Pharmacother. 2003;4:2193–2204.
   PubMed Web of Science ®Google Scholar
• Romsing J, Moiniche S. A systematic review of COX-2 inhibitors compared to traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesthisiol Scand. 2004;48:525–546.
   PubMed Web of Science ®Google Scholar
• Karakiulakis G, Papanikolaou C, Jankovic SM, Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon. Invasion Metastasis 1997;17:158–168.
   PubMedGoogle Scholar
• Ehrlich HP, Tarver H, Hunt TK. Effects of vitamin A and glucocorticoids upon inflammation and collagen synthesis. Ann Surg. 1973;177:222–227.
   PubMed Web of Science ®Google Scholar
• te Velde EA, Voest EE, van Gorp JM, Adverse effects of the antiangiogenic agent angiostatin on the healing of experimental colonic anastomoses. Ann Surg Oncol. 2002;9(3):303–309.
   PubMedGoogle Scholar
• Mall JW, Schwenk W, Phillipp AW, Intraperitoneal administration of the angiogenesis inhibitor thalidomide does not impair anastomotic healing following large bowel resection in a rabbit model. World J Surg. 2003;27(10):1119–1123.
   PubMedGoogle Scholar
• de Sousa JB, Soares EG, Aprilli F. Effects of diclofenac sodium on intestinal anastomotic healing. Experimental study on the small intestine of rabbits. Dis Colon Rectum. 1991;34:613–617.
   PubMed Web of Science ®Google Scholar
• de Hingh IHJT, van Goor H, de Man BM, Selective cyclo-oxygenase 2 inhibition affects ileal but not anastomotic healing in the early postoperative period. Br J Surg. 2006;93:489–497.
   PubMedGoogle Scholar
• Jones MK, Wang H, Peskar BM, Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med. 1999;5:1418–1423.
   PubMed Web of Science ®Google Scholar
• Chu J, Lloyd FL, Trifan OC, Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor associated angiogenesis and growth in pancreatic cancer. Mol Cancer Ther. 2003;2:1–7.
   PubMed Web of Science ®Google Scholar
• Tsujii M, Kawano S, Tsuji S, Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705–716.
   PubMed Web of Science ®Google Scholar
• August DA, Serrano D, Poplin E. “Spontaneous,” delayed colon and rectal anastomotic complications associated with bevacizumab therapy. J Surg Oncol. 2008;97:180–185.
   PubMed Web of Science ®Google Scholar
• Pavlidis ET, Ballas KD, Symeonidis NG, The effect of bevacizumab on colon anastomotic healing in rats. Int J Colorect Dis. 2010;25(12):1465–1473.
   PubMedGoogle Scholar
• de Hingh IH, Lomme RM, van Goor H, Changes in gelatinase activity in the gastrointestinal tract after anastomotic construction in the ileum or colon. Dis Colon Rectum. 2005;48(11):2133–2141.
   PubMed Web of Science ®Google Scholar
• Syk I, Argen MS, Adawi D, Inhibition of matrix metalloproteinases enhances breaking strength of colonic anastomoses in an experimental model. Br J Surg. 2001;88:228–234.
   PubMed Web of Science ®Google Scholar
• Klein SA, Anderson GL, Kennedy AB, The effects of a broad-spectrum matrix metalloproteinase inhibitor on characteristics of wound healing. J Invest Surg. 2002;15(4):199–207.
   PubMed Web of Science ®Google Scholar
• Brasken P, Lehto M, Renvall S. Changes in the connective tissue composition of the submucosal layer of colonic anastomosis. An immunohistologic study in rats. Acta Chir Scand. 1989;155:413–419.
   PubMedGoogle Scholar
• Siemonsma MA, de Hingh IHJT, de Man BM, Doxycycline improves wound strength after intestinal anastomosis in the rat. Surgery 2003;133:268–276.
   PubMed Web of Science ®Google Scholar
• Pinheiro RM, Calixto JB. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm Res. 2002;51:603–610.
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Mazzon E, Serraino I, Celecoxib, a selective cyclooxygenase-2 inhibitor reduced the severity of experimental colitis induced dinitrobenzene sulfonic acid in rats. Eur J Pharmacol. 2001;431:91–102.
   PubMed Web of Science ®Google Scholar
• Hu PJ, Yu J, Zeng ZR, Chemoprevention of gastric cancer by celecoxib in rats. Gut 2004;53:195–200.
   PubMed Web of Science ®Google Scholar
• Neuss H, Raue W, Muller V, Effects of cyclooxygenase inhibition on anastomotic healing following large bowel resection in a rabbit model –a randomized, blinded, placebo-controlled trial. Int J Colorectal Dis. 2009;24:551–557.
   PubMedGoogle Scholar
• Cahill RA, Sheehan KM, Scanlon RW, Effects of a selective cyclo-oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity. Br J Surg. 2004;91:1613–1618.
   PubMedGoogle Scholar
• Stichtenoth DO, Frolich JC. The second generation of COX-2 inhibitors: what advantages do the newest offer? Drugs 2003;63:33–45.
   PubMed Web of Science ®Google Scholar
• Kerbel RS. Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results. J Clin Oncol. 2001;19:45S–51S.
   Google Scholar
• Kerbel R, Folkmann J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002;2:727–739.
   PubMed Web of Science ®Google Scholar
• Keller JJ, Giardello FM. Chemoprevention strategies using NSAIDs and COX-2 inhibitors. Cancer Biol Ther. 2003;2(Suppl 1):S140–S149.
   Google Scholar
• Chun KS, Surh YJ. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem Pharmacol. 2004;68:1089–1100.
   PubMed Web of Science ®Google Scholar
• Holte K, Andersen J, Hjort Jakobsen D, Cyclo-oxygenase 2 inhibitors and the risk of anastomotic leakage after fast-track colonic surgery. Br J Surg. 2009;96:650–654.
   PubMed Web of Science ®Google Scholar
• Scharfenberg M, Raue W, Junghans T, “Fast-track” rehabilitation after colonic surgery in elderly patients –is it feasible? Int J Colorectal Dis. 2007;22:1469–1474.
   PubMed Web of Science ®Google Scholar